COLA Gets Extension of Deeming Reapproval in Pathology and Lab Accreditation
CMS granted COLA an extension of its deeming authority for an extra six years under the Clinical Laboratory Improvement Amendments of 1988.
CMS granted COLA an extension of its deeming authority for an extra six years under the Clinical Laboratory Improvement Amendments of 1988.
To ensure business continuity and effective leadership, the Board formed the Office of the Chief Executive Officer, led by Michael Iskra.
CLP Editor Chris Wolski examines the need for LDT regulations, and issues an industry-wide call to action.
DiaCarta has received accreditation by the College of American Pathologists (CAP) for its CLIA certified lab.
CMS and the CDC issued Final Rulemaking [CMS-3326-F] to update the CLIA fees and clarify the CLIA fee regulations.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Myriad Genetics will acquire Intermountain Precision Genomics' Precise Tumor Test, the Precise Liquid Test, and a CLIA-certified laboratory.
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.